Risk management in HIV/AIDS: ethical and economic issues concerning the restriction of HAART access only to adherent patients

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Chawana, Richard
dc.date.accessioned 2011-02-15T11:27:50Z
dc.date.available 2011-02-15T11:27:50Z
dc.date.issued 2011-02-15
dc.identifier.uri http://hdl.handle.net/10539/9038
dc.description MSc (Med), Bioethics and Health Law, Faculty of Health Sciences, University of the Witwatersrand en_US
dc.description.abstract South Africa, like many other developing nations, is faced with the challenge of mobilising resources to fight the HIV/AIDS pandemic. There is a huge budget gap between the ideal and actual funding provided to achieve universal access to highly active antiretroviral therapy (HAART), which leads to the inevitable rationing of HAART. Although healthcare spending has been increasing in South Africa, new demands are being placed on the HAART roll out programmes. This is particularly due to the emergence of HIV drug resistance (HIVDR). Because non-adherence to HAART is strongly linked to drug resistance, this is a major threat to any successful HAART programme. In the face of restricted resources, this research report looks at some of the ethical and economic implications of non-adherence to HAART. I suggest that there is merit in considering that HAART be restricted only to adherent patients. en_US
dc.language.iso en en_US
dc.subject HAART en_US
dc.subject ethics en_US
dc.subject adherent patients en_US
dc.subject access en_US
dc.subject HIV/AIDS en_US
dc.title Risk management in HIV/AIDS: ethical and economic issues concerning the restriction of HAART access only to adherent patients en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search WIReDSpace


Browse

My Account

Statistics